Opendata, web and dolomites

JOINTPROMISE SIGNED

PRECISION MANUFACTURING OF MICROENGINEERED COMPLEX JOINT IMPLANTS

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 JOINTPROMISE project word cloud

Explore the words cloud of the JOINTPROMISE project. It provides you a very rough idea of what is the project "JOINTPROMISE" about.

robotics    cover    minipig    regenerating    prevent    articular    inbuilt    3d    prevalent    demand    paradigm    animal    adult    regeneration    jointpromise    scaled    repair    socioeconomic    grade    joints    implants    solution    microtissue    patient    precise    bioprinting    breakthroughs    society    patterned    underlying    execute    technologies    there    models    implant    biological    gmp    mostly    possess    disease    containing    hence    biologic    joint    shift    vascularised    predictively    time    affordable    blocks    allowed    volume    engineered    population    building    humans    deep    osteoarthritis    structure    microtissues    regenerative    organoid    clinical    rising    osteochondral    tissue    implantation    arthritic    feasibility    paves    living    25    efficacy    defect    oa    manual    cartilaginous    defects    bioreactor    manufacturing    bone    automated    convincing    cartilage    adopting    integration    producing    entire    rate    strive    surface    model    ageing    platform    unmet    structures   

Project "JOINTPROMISE" data sheet

The following table provides information about the project.

Coordinator
KATHOLIEKE UNIVERSITEIT LEUVEN 

Organization address
address: OUDE MARKT 13
city: LEUVEN
postcode: 3000
website: www.kuleuven.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 7˙901˙115 €
 EC max contribution 7˙901˙115 € (100%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SC1-2019-Single-Stage-RTD
 Funding Scheme RIA
 Starting year 2020
 Duration (year-month-day) from 2020-01-01   to  2024-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    KATHOLIEKE UNIVERSITEIT LEUVEN BE (LEUVEN) coordinator 1˙683˙000.00
2    FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. DE (MUNCHEN) participant 1˙745˙487.00
3    UNIVERSITEIT MAASTRICHT NL (MAASTRICHT) participant 1˙694˙275.00
4    POIETIS FR (PESSAC) participant 1˙436˙687.00
5    IDRYMA TECHNOLOGIAS KAI EREVNAS EL (IRAKLEIO) participant 783˙750.00
6    STEMCELL TECHNOLOGIES UK LTD UK (CAMBRIDGE) participant 557˙915.00

Map

 Project objective

There is convincing evidence, in animal models and in humans, that deep osteochondral defects of the joint surface lead to a high rate of osteoarthritis (OA) over time. The disease process in OA, the most prevalent arthritic disease affecting 25% of the adult population, involves the entire joint affecting both the articular cartilage and the underlying bone. Hence it is crucial to consider the entire osteochondral unit as a target for repair. Tissue engineered implants could provide a solution for the regeneration of this type of defects and prevent the development of OA. This project aims to address this unmet clinical need by developing complex joint implants that will possess the spatially inbuilt biologic information for regenerating these challenging defects. Breakthroughs in organoid technologies have allowed the development of cartilaginous microtissue structures that can predictively execute regenerative programmes upon implantation. These microtissues can be used as building blocks for bottom-up 3D bioprinting of living joint implants. In order to be able to produce scaled-up implants containing at the same time a highly precise structure, integration of bioprinting technologies is needed. Moreover in order to cover rising clinical demand the whole manufacturing process, which is mostly manual today, will need to be automated adopting robotics, bioprinting and bioreactor technologies. In order to demonstrate implant feasibility and efficacy, large osteochondral defect repair will be studied in the minipig, a large animal model relevant to the patient. Taken together we strive to develop an automated, GMP-grade platform producing large, patterned and vascularised joint implants providing also a paradigm shift for generic automated manufacturing of organoid-based tissue implants. JOINTPROMISE paves the way for high-volume, affordable production of entire biological joints, addressing a major socioeconomic challenge of the European ageing society.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "JOINTPROMISE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "JOINTPROMISE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

AutoCRAT (2020)

Automated Cellular Robot-Assisted Technologies for translation of discovery-led research in Osteoarthritis

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

MISTRAL (2020)

Microbiome-based stratification of individuals at risk of HIV-1 acquisition, chronic clinical complications,antimicrobial drug resistance,and unresponsiveness to therapeutic HIV-1 vaccination

Read More